Sign in

    Thomas W. Burns

    Chairman of the Board and CEO at Glaukos Corp
    Board
    Since 2002
    Age
    63 years
    Education
    Holds a Bachelor of Arts degree from Yale University.
    Tenure
    Joined GKOS in 2002 as a Director and has served as CEO since that year, being promoted to Chairman of the Board in 2021.

    Also at Glaukos Corp

    ART
    Alex R. Thurman
    Senior Vice President & CFO
    JEG
    Joseph E. Gilliam
    President and COO
    TN
    Tomas Navratil
    Chief Development Officer

    About

    Thomas W. Burns has built an impressive career in the medical device and pharmaceutical industries, beginning with key leadership roles at companies such as Chiron Vision Corporation and Bausch & Lomb, where he held titles including Senior Vice President and General Manager and Vice President, Global Strategy.

    Over the years, his strategic vision has driven innovations and market growth in ophthalmology. His leadership at GKOS began in 2002, where he assumed the role of Director and later became CEO, demonstrating a consistent record of success and a deep understanding of the industry.

    Throughout his career, his contributions have spanned beyond his primary executive responsibilities at GKOS. In addition to steering the company through critical acquisitions and expansions, he has also taken on roles such as serving as an entrepreneur in residence and holding directorship positions at other companies, reflecting his multifaceted approach to business leadership.

    His professional journey underscores a commitment to excellence and a passion for innovation that continues to shape the future of the medical device sector.

    $GKOS Performance Under Thomas W. Burns

    Past Roles

    OrganizationRoleDate Range
    Glaukos Corporation (GKOS) President and Chief Executive Officer N/A
    Versant Ventures Management, LLC Entrepreneur in Residence N/A
    Bausch & Lomb Vice President, Global Strategy and General Manager, Refractive Surgery 1998 to 2000
    Chiron Vision Corporation Senior Vice President and General Manager 1990 to 1997

    External Roles

    OrganizationRoleDate Range
    Pulmonx Corporation (NASDAQ:LUNG) Board Member Since 2020

    Fixed Compensation

    Data from  FY 2023
    Component NameAmount ($)Payment ScheduleAdditional Details
    Salary765,000 AnnualAnnual Base Salary for 2023
    Severance Payment - Involuntary Termination1,147,500 Upon Involuntary TerminationFixed severance payment
    Severance Payment - Involuntary Termination in Connection with a Change in Control1,530,000 Upon Involuntary Termination with Change in ControlFixed severance payment

    Performance Compensation

    Data from  FY 2023

    No information available on performance compensation for 2023